SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-21-000033
Filing Date
2021-05-07
Accepted
2021-05-07 16:17:30
Documents
74
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alim-20210331x10q.htm   iXBRL 10-Q 2711711
2 EX-10.14.F alim-20210331xex10_14f.htm EX-10.14.F 174689
3 EX-31.1 alim-20210331xex31_1.htm EX-31.1 20936
4 EX-31.2 alim-20210331xex31_2.htm EX-31.2 21153
5 EX-32.1 alim-20210331xex32_1.htm EX-32.1 16051
  Complete submission text file 0001267602-21-000033.txt   9944675

Data Files

Seq Description Document Type Size
6 EX-101.SCH alim-20210331.xsd EX-101.SCH 46058
7 EX-101.CAL alim-20210331_cal.xml EX-101.CAL 60151
8 EX-101.DEF alim-20210331_def.xml EX-101.DEF 185519
9 EX-101.LAB alim-20210331_lab.xml EX-101.LAB 470195
10 EX-101.PRE alim-20210331_pre.xml EX-101.PRE 368349
11 EXTRACTED XBRL INSTANCE DOCUMENT alim-20210331x10q_htm.xml XML 2098349
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 21902923
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences